Abstract

Objective Atypical parathyroid adenoma is a rare neoplasm, showing atypical histological features intermediate between classic benign adenoma and the rarest parathyroid carcinoma, whose the clinical behaviour and outcome is not yet understood or predictable. Up to date only two cases of atypical adenoma were found associated to a MEN1 syndrome, and only one was proved to carry a pathogenic variant of the MEN1 gene. Design We report the clinical, histologic, and molecular findings of a 44-year-old woman, presenting with a histologically proved atypical parathyroid adenoma with an apparent aggressive behaviour. Methods and Results CDC73 gene was screened at germline and somatic levels with no results. Whole exome sequencing performed on DNA extracted from blood leukocytes and tumour tissue revealed a somatic MEN1 gene heterozygous variant, c.912+1G > A, of the splicing donor site of exon 6. On immunohistochemistry, downregulation of the menin protein expression in the neoplastic cells was also observed. Conclusions We report the second case of a rare association of a somatic MEN1 gene mutation in a patient with atypical parathyroid adenoma. We suggest that MEN1 gene could be an underestimate genetic determinant of these rare histological entities, and we highlight the utility of a complete genetic screening protocol, by the use of next-generation sequencing technology in such undetermined clinical cases with no frank clinical presentation.

Highlights

  • Primary hyperparathyroidism is the third most common endocrine disease after diabetes and thyroid disorders [1]

  • Recognizing both parathyroid carcinoma (PC), especially in absence of metastases, and AA is not clear-cut in all cases. e PC presents with severe hypercalcemia (>14 mmg/dL), with a parathyroid lesion of 3 cm in average [3] with a firm adherence and invasion of surrounding structures [4]

  • AA is a histology entity thought to be located in an intermediate position between the more aggressive and rare PC and the common parathyroid adenoma (PA)

Read more

Summary

Introduction

Primary hyperparathyroidism (pHPT) is the third most common endocrine disease after diabetes and thyroid disorders [1]. Less than 1% of cases includes the rare parathyroid carcinoma (PC), while an intermediate histology entity, between the PA and the PC, defined as atypical adenoma (AA) has been reported with a frequency ranging from 0.5% to 4.4% with highest frequency for the selected ethnic group [1, 2]. Recognizing both PC, especially in absence of metastases, and AA is not clear-cut in all cases. In 70% of sporadic PC cases, as well as in 15–20%, associated to International Journal of Endocrinology hyperparathyroidism with jaw tumour syndrome (HPT-JT), pathogenic variants of the CDC73 gene were found, with the corresponding loss of expression of the encoded parafibromin protein, on the tumour tissues [5,6,7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call